Attitudes towards ferric derisomaltose among Swiss patients with iron deficiency and their treating physicians: the prospective, observational Real-CHOICE study
Archives of Gynecology and Obstetrics · 2025
DOI: 10.1007/s00404-025-08085-5 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Archives of Gynecology and Obstetrics, 2025. Verfasst von Petra Stute und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Inselspital Bern, Friedbuehlstrasse 19, 3010, Bern, Switzerland. petra.stute@insel.ch. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Ferric Compounds, Maltose, Attitude of Health Personnel. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pierre Fabre Pharma AG, University of Bern.
Abstract (Originalsprache)
Purpose
Iron deficiency (ID) often leads to iron deficiency anemia (IDA). Oral iron supplements are frequently associated with gastrointestinal intolerance and poor adherence. Ferric derisomaltose (FDI), a single high-dose intravenous (IV) infusion, is another option. The real-world Real-CHOICE study investigated the attitudes of patients with IDA and ID without anemia (IDNA) towards IV iron therapy. Secondary objectives were the effectiveness and safety of FDI.
Methods
Real-CHOICE (NCT04318405) enrolled adults with IDA or IDNA in Switzerland. Custom questionnaires evaluated attitudes and treatment satisfaction at baseline and follow-up (≥ 12 weeks). Hemoglobin, ferritin, and transferrin saturation levels, and treatment-emergent adverse events (TEAEs) were assessed.
Results
Of 319 patients (114 with IDA, 205 with IDNA) who received FDI, most were female (n = 305, 93.9%) and aged < 65 years (n = 298, 91.7%). Over three-quarters of patients were not hesitant to receive IV iron treatment at baseline (n = 228, 76.3%) and follow-up (n = 194, 78.2%). The proportion of patients whose attitude towards receiving IV iron therapy remained stable or improved at follow-up versus baseline was 86.1% (n = 204/237). Of 195 patients with available data, mean (standard deviation) changes from baseline to follow-up in hemoglobin, ferritin, and transferrin saturation levels were 1.15 (1.50) g/dL, 144.87 (131.77) µg/L, and 8.71% (13.29%), respectively. TEAEs and adverse drug reactions occurred in 76 (23.8%) and 22 patients (6.9%), respectively.
Conclusion
Real-CHOICE revealed favorable attitudes of patients and physicians towards IV iron therapies, particularly FDI, in a real-world setting. Improved hematologic parameters and favorable safety highlight FDI’s potential as a clinically effective treatment for ID and IDA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Inselspital Bern, Friedbuehlstrasse 19, 3010, Bern, Switzerland. petra.stute@insel.ch.
- Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland.
- General Practice Brauereistrasse, Uster, Switzerland.
- Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
ORCID-Profile: Petra Stute
Förderung
- Pierre Fabre Pharma AG
- University of Bern
Zitieren
APA
Stute, P., Krayenbühl, P. A., & Vavricka, S. R. (2025). Attitudes towards ferric derisomaltose among Swiss patients with iron deficiency and their treating physicians: the prospective, observational Real-CHOICE study. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-025-08085-5
Vancouver
Stute P, Krayenbühl PA, Vavricka SR. Attitudes towards ferric derisomaltose among Swiss patients with iron deficiency and their treating physicians: the prospective, observational Real-CHOICE study. Archives of Gynecology and Obstetrics. 2025. doi:10.1007/s00404-025-08085-5
BibTeX
@article{Stute2025,
author = {Stute, Petra and Krayenbühl, Pierre-Alexandre and Vavricka, Stephan R},
title = {Attitudes towards ferric derisomaltose among Swiss patients with iron deficiency and their treating physicians: the prospective, observational Real-CHOICE study},
journal = {Archives of Gynecology and Obstetrics},
year = {2025},
doi = {10.1007/s00404-025-08085-5}
}
EUVIMED